Home / Resource Library / Management of Canadian Patients With Refractory or Relapsed Diffuse Large B-Cell Lymphoma in the Real World: A Subanalysis of the RE-MIND2 Study

Management of Canadian Patients With Refractory or Relapsed Diffuse Large B-Cell Lymphoma in the Real World: A Subanalysis of the RE-MIND2 Study

Membership Organisation

Healthcare Professional

Affected by Lymphoma

Researcher or Advocate

Management of Canadian Patients With Refractory or Relapsed Diffuse Large B-Cell Lymphoma in the Real World: A Subanalysis of the RE-MIND2 Study